HKUMed discovered that acute SARS-CoV-2 infection impairs human immune defences
On Aug. 6, 2020, researchers at the AIDS Institute, Department of Microbiology and State Key Laboratory of Emerging…
On Aug. 6, 2020, researchers at the AIDS Institute, Department of Microbiology and State Key Laboratory of Emerging…
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
On Aug. 6, 2020, Organicell Regenerative Medicine announced that the FDA had approved two outpatient Emergency Investigational New…
On Aug. 6, 2020, Novavax announced a license agreement with Serum Institute of India Private Limited (SIIPL) for…
On Aug. 5, 2020, a randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen…
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
On Aug. 5, 2020, the investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus…
On Aug. 5, 2020, the Tecan Group and Thermo Fisher Scientific announced a collaboration to enable scaled-up COVID-19…
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
On Aug. 5, 2020,Thermo Fisher Scientific announced a new highly automated, real-time PCR solution designed to analyze up…
On Aug. 5, 2020, Heat Biologics highlighted the importance of T cell immunity in preventing COVID-19 in a…
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
On Aug. 5, 2020, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and…
On Aug. 4, 2020, the NIH announced that patients admitted with COVID-19 at select hospitals may now volunteer…
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they had initiated a ARTI-19 randomized, controlled, multi-site India…
On Aug. 4, 2020, Precipio announced it had completed the internal validation of the U.S. Food and Drug…
On Aug. 4, 2020, Innovation Pharma reported receiving an update from a U.S. Regional Biocontainment Laboratory (RBL) based…
On Aug. 4, 2020, Abiomed announced the FDA had issued an emergency use authorization (EUA) for its left-sided…
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
On Aug. 3, 2020, members of the COVID R&D Alliance AbbVie, Amgen and Takeda Pharma announced the first…
On Aug. 3, 2020, ImmunityBio announced positive preclinical results for its human Ad5 vaccine candidate that contains both…
On Aug. 3, 2020, the La Jolla Institute for Immunology (LJI) announced a $1 million gift from GHR…
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
On Aug. 3, 2020, Waisman Biomanufacturing at the University of Wisconsinï¾–Madison announced it was partnering with Heat Biologics…
On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
On Jul. 31, 2020, Yale researchers reported that differing immune system responses of patients with COVID-19 can help…